AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12145055 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium 0.2 mg/kg injected over 30 s
Number of subjects: 206
Study 10204554 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 hours of intravenous cefoxitin (1 g q6h)
Number of subjects: 314
Study 10204554 — intervention group
Group type: COMPARATOR
Intervention: 5 days of intravenous cefoxitin
Number of subjects: 314
Study 8706191 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (OND) 150 micrograms x kg(‐1)
Number of subjects: 276
Study 8706191 — intervention group
Group type: COMPARATOR
Intervention: Droperidol (DROP) 50 micrograms x kg(‐1)
Number of subjects: 276
Study 8706191 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (OND)
Number of subjects: 276
Study 8706191 — intervention group
Group type: COMPARATOR
Intervention: Droperidol (DROP)
Number of subjects: 276
Study 2079453 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin (three-day course)
Number of subjects: 1429
Study 2079453 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin (two to three days)
Number of subjects: 1429
Study 2079453 — intervention group
Group type: COMPARATOR
Intervention: Teicoplanin (non-toxic antibiotic)
Number of subjects: 1429
Study 7418154 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg/day for 8 weeks
Number of subjects: 12
Study 31992459 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin alone
Number of subjects: 40
Study 31992459 — intervention group
Group type: COMPARATOR
Intervention: Lobeglitazone alone
Number of subjects: 40
Study 31992459 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of lobeglitazone and dapagliflozin
Number of subjects: 40
Study 31652512 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized energy-restricted diet
Number of subjects: 98
Study 31652512 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher adherence to the Mediterranean Diet (MedDiet)
Number of subjects: 98
Study 31652512 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted diets
Number of subjects: 98
Study 31652512 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant capacity of the diet
Number of subjects: 98
Study 29256406 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (250 mg/day of magnesium oxide)
Number of subjects: 40
Study 29256406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 24676874 — intervention group
Group type: EXPERIMENTAL
Intervention: School readiness intervention focusing on children's self-regulation skills and parenting
Number of subjects: 0
Study 23829828 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (200 U/kg intravenously three days before operation and 100 U/kg at operation time)
Number of subjects: 100
Study 23829828 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100
Study 21454236 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro with meals and basal insulin glargine
Number of subjects: 60
Study 19358497 — intervention group
Group type: EXPERIMENTAL
Intervention: Meridian three-combined therapy (thread embedding, blood-letting puncture, auricular point pressing)
Number of subjects: 233
Study 19358497 — intervention group
Group type: COMPARATOR
Intervention: Di yin Tablets (5 tablets, twice daily)
Number of subjects: 233
Study 19358497 — intervention group
Group type: EXPERIMENTAL
Intervention: Meridian three-combined therapy
Number of subjects: 233
Study 19358497 — intervention group
Group type: COMPARATOR
Intervention: Di yin Tablets
Number of subjects: 233
Study 16920998 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial interventions aimed at decreasing caregiver depression and burden
Number of subjects: 694
Study 16920998 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 694
Study 12952724 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenursing service using an analogue videophone linked with a physiological monitoring device
Number of subjects: 0
Study 12952724 — intervention group
Group type: COMPARATOR
Intervention: Existing home care service (comparison arm)
Number of subjects: 0
Study 10983644 — intervention group
Group type: EXPERIMENTAL
Intervention: Cidofovir 5 mg/kg once weekly for 2 weeks followed by low-dose maintenance cidofovir therapy (3 mg/kg)
Number of subjects: 58
Study 10983644 — intervention group
Group type: EXPERIMENTAL
Intervention: Cidofovir 5 mg/kg once weekly for 2 weeks followed by high-dose maintenance cidofovir therapy (5 mg/kg)
Number of subjects: 58
Study 10983644 — intervention group
Group type: EXPERIMENTAL
Intervention: Cidofovir
Number of subjects: 58
Study 9098014 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 16
Study 9098014 — intervention group
Group type: COMPARATOR
Intervention: Noncaloric fruit drink (250 mL)
Number of subjects: 16
Study 7939946 — intervention group
Group type: COMPARATOR
Intervention: 300 mg polymorph A
Number of subjects: 958
Study 7939946 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg polymorph C
Number of subjects: 958
Study 7939946 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg polymorph C
Number of subjects: 958
Study 7939946 — intervention group
Group type: COMPARATOR
Intervention: 100 mg polymorph C bid for 3 days (standard dose control)
Number of subjects: 958
Study 7939946 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 958
Study 2428795 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantle field irradiation
Number of subjects: 318
Study 2428795 — intervention group
Group type: COMPARATOR
Intervention: MOPP chemotherapy
Number of subjects: 318
Study 2428795 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended field irradiation
Number of subjects: 318
Study 2428795 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD chemotherapy
Number of subjects: 318
Study 31207400 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (DES)
Number of subjects: 88
Study 31207400 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-coated balloons (DCB)
Number of subjects: 88
Study 29055674 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise programme (aerobic and resistance exercises) plus standard antenatal care
Number of subjects: 38
Study 29055674 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 38
Study 27855051 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin
Number of subjects: 120
Study 27855051 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 120
Study 23980529 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) or Methotrexate + Cyclosporin A (MTX/CyA) treatment for 1 year
Number of subjects: 160
Study 23980529 — intervention group
Group type: COMPARATOR
Intervention: Baseline characteristics (not an intervention)
Number of subjects: 160
Study 22537359 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (0.5 mg/day for 6 weeks, 2.5 mg for 2 weeks, then 5 mg/day for 6 weeks)
Number of subjects: 20
Study 22537359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22537359 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (0.13-0.15 mg/kg/day)
Number of subjects: 20
Study 22537359 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (≥0.18 mg/kg/day)
Number of subjects: 20
Study 22537359 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine
Number of subjects: 20
Study 20097325 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide implant placement
Number of subjects: 255
Study 20097325 — intervention group
Group type: COMPARATOR
Intervention: Systemic corticosteroid therapy (and immunosuppression when indicated)
Number of subjects: 255
Study 18088560 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (10 mg or 20 mg)
Number of subjects: 30
Study 18088560 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (titrated in Phase II)
Number of subjects: 30
Study 18088560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 16893381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 16893381 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 320
Study 16893381 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 320
Study 16893381 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tropisetron and dexamethasone
Number of subjects: 320
Study 15221995 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNFR‐I
Number of subjects: 139
Study 15221995 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNFR‐II
Number of subjects: 139
Study 15221995 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125
Number of subjects: 139
Study 11698939 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 microg/kg at the end of cardiopulmonary bypass)
Number of subjects: 66
Study 11698939 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 9440364 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward translation (L1 to L2)
Number of subjects: 0
Study 9440364 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward translation (L2 to L1)
Number of subjects: 0
Study 9440364 — intervention group
Group type: EXPERIMENTAL
Intervention: Matching L1 item to a category name
Number of subjects: 0
Study 9440364 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment procedure for response production and concept retrieval times
Number of subjects: 0
Study 7513587 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal teaching and a color‐coded medication schedule
Number of subjects: 80
Study 7513587 — intervention group
Group type: COMPARATOR
Intervention: Verbal teaching only
Number of subjects: 80
Study 3118351 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphinpyrazone
Number of subjects: 55
Study 3118351 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 55
Study 28993887 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 4.5 mg/m2/day (target blood trough 5-15 mg/dl)
Number of subjects: 33
Study 28993887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 27049055 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of emtricitabine (EMT) 200 mg and tenofovir disoproxil fumarate (TNF) 300 mg
Number of subjects: 24
Study 25373630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal rapid-acting insulin glulisine
Number of subjects: 9
Study 23287844 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily diaries (asthma control days - ACDs)
Number of subjects: 182
Study 23287844 — intervention group
Group type: COMPARATOR
Intervention: Retrospective questionnaires (Asthma Control Test - ACT)
Number of subjects: 182
Study 20094068 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-0 Prolene suture (group 1)
Number of subjects: 90
Study 20094068 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-0 Prolene suture (group 2)
Number of subjects: 90
Study 20094068 — intervention group
Group type: COMPARATOR
Intervention: Cox regression analysis
Number of subjects: 90
Study 18221838 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (20 IU)
Number of subjects: 36
Study 18221838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 17198210 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral dexamethasone (0.6 mg/kg to a maximum of 18 mg)
Number of subjects: 0
Study 17198210 — intervention group
Group type: COMPARATOR
Intervention: 5 days of twice-daily prednisolone (1 mg/kg per dose to a maximum of 30 mg)
Number of subjects: 0
Study 17198210 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral dexamethasone
Number of subjects: 0
Study 17198210 — intervention group
Group type: COMPARATOR
Intervention: 5 days of twice-daily prednisolone
Number of subjects: 0
Study 14572560 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (QT)
Number of subjects: 223
Study 14572560 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (DT)
Number of subjects: 223
Study 14572560 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole and placebo therapy (OPl)
Number of subjects: 223
Study 14572560 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori negative patients
Number of subjects: 223
Study 14572560 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori positive patients
Number of subjects: 223
Study 14572560 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori positive and negative patients
Number of subjects: 223
Study 10934074 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI)
Number of subjects: 74
Study 10934074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 8921924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) at a mean dose of 2.7 +/- 1.1 mg/kg/day (n = 15)
Number of subjects: 44
Study 8921924 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (Chl) at a dose of 100 mg/day (n = 11)
Number of subjects: 44
Study 1633284 — intervention group
Group type: EXPERIMENTAL
Intervention: Positron emission tomography with H2(15)O injection
Number of subjects: 0
Study 2951011 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 56
Study 2951011 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 56
Study 29345011 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimethod venous thromboembolism prevention education plan (video, pamphlet, verbal instruction)
Number of subjects: 66
Study 29345011 — intervention group
Group type: COMPARATOR
Intervention: Usual instructional pamphlet
Number of subjects: 66
Study 27982389 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 30
Study 27982389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 27982389 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 24606847 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Breathing Coordinator (ABC)
Number of subjects: 43
Study 24606847 — intervention group
Group type: COMPARATOR
Intervention: No Active Breathing Coordinator (No-ABC)
Number of subjects: 43
Study 26856040 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected children
Number of subjects: 875
Study 26856040 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-uninfected children
Number of subjects: 875
Study 20177839 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mm laterally wedged insole
Number of subjects: 91
Study 20177839 — intervention group
Group type: COMPARATOR
Intervention: Valgus brace
Number of subjects: 91
Study 18318925 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-lead event recorder and telemedicine call centre access
Number of subjects: 1500
Study 18318925 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1500
Study 16029791 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (59.4 Gy external beam radiotherapy in 1.8 Gy fractions)
Number of subjects: 114
Study 16029791 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with 5-FU (1,000 mg/m2/day for 4 days by continuous infusion Days 2-5 and 28-31) and MMC (10 mg/m2 on Day 2)
Number of subjects: 114
Study 12885977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone 0.6 mg/kg for 14 days
Number of subjects: 524
Study 12885977 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 524
Study 12885977 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed ex-smokers
Number of subjects: 524
Study 12885977 — intervention group
Group type: COMPARATOR
Intervention: Placebo or fluticasone propionate treatment
Number of subjects: 524
Study 12885977 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone response
Number of subjects: 524
Study 10589440 — intervention group
Group type: EXPERIMENTAL
Intervention: Balm mint cream (1% Lo-701) applied topically four times daily for five days
Number of subjects: 66
Study 10589440 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied topically four times daily for five days
Number of subjects: 66
Study 7546806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime (CFX)
Number of subjects: 385
Study 7546806 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin (CFZ)
Number of subjects: 385
Study 1778138 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (1 mg)
Number of subjects: 91
Study 1778138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 7008825 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone oenanthate (NET‐OEN)
Number of subjects: 1678
Study 7008825 — intervention group
Group type: COMPARATOR
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 1678
Study 31780142 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 120
Study 31780142 — intervention group
Group type: COMPARATOR
Intervention: Direct invasive coronary angiography (ICA)
Number of subjects: 120
Study 31122656 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised combined intermittent aerobic, muscle strength and home-based walking training programs
Number of subjects: 32
Study 31122656 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 29202863 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Dignity Intervention (FDI) offered in addition to standard psychological care
Number of subjects: 126
Study 29202863 — intervention group
Group type: COMPARATOR
Intervention: Standard psychological care
Number of subjects: 126
Study 26613136 — intervention group
Group type: EXPERIMENTAL
Intervention: Columbia Suicide Severity Rating Scale (C‐SSRS)
Number of subjects: 199
Study 26613136 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide Tracking Scale (STS)
Number of subjects: 199
Study 26613136 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheehan Suicidality Tracking Scale (S‐STS)
Number of subjects: 199
Study 26613136 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrater agreement
Number of subjects: 199
Study 25039403 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 148
Study 25039403 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 148
Study 22939807 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular apex pacing
Number of subjects: 59
Study 22939807 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventricular septum pacing
Number of subjects: 59
Study 22939807 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventricular septum pacing with anterior RV lead position
Number of subjects: 59
Study 22939807 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventricular septum pacing with mid-septal lead position
Number of subjects: 59
Study 22939807 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular pacing (both groups)
Number of subjects: 59
Study 19204845 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent hydrogel pad
Number of subjects: 21
Study 19204845 — intervention group
Group type: COMPARATOR
Intervention: Fluid gel
Number of subjects: 21
Study 17043681 — intervention group
Group type: EXPERIMENTAL
Intervention: Methenamine Hippurate (MH) 1 g twice-daily
Number of subjects: 305
Study 17043681 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry tablets 800 mg twice-daily
Number of subjects: 305
Study 17043681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 15182771 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 113
Study 15182771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 11583639 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antimicrobials
Number of subjects: 188
Study 11583639 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-switch therapy
Number of subjects: 188
Study 11583639 — intervention group
Group type: COMPARATOR
Intervention: Parenteral antimicrobials
Number of subjects: 188
Study 11583639 — intervention group
Group type: COMPARATOR
Intervention: Full course of parenteral antibiotics
Number of subjects: 188
Study 10886696 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 14
Study 10886696 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 14
Study 8993086 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 33
Study 1319873 — intervention group
Group type: EXPERIMENTAL
Intervention: Temafloxacin 800mg
Number of subjects: 12
Study 1319873 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin 800mg
Number of subjects: 12
Study 1319873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1319873 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin-theophylline administration
Number of subjects: 12
Study 6383512 — intervention group
Group type: EXPERIMENTAL
Intervention: Angelchik prosthesis
Number of subjects: 52
Study 6383512 — intervention group
Group type: COMPARATOR
Intervention: Fundoplication
Number of subjects: 52
Study 30624719 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 21028
Study 30624719 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21028
Study 30624719 — intervention group
Group type: COMPARATOR
Intervention: Edoxaban vs. Warfarin
Number of subjects: 21028
Study 29967368 — intervention group
Group type: EXPERIMENTAL
Intervention: NFE (upregulation of emotion areas)
Number of subjects: 43
Study 29967368 — intervention group
Group type: COMPARATOR
Intervention: NFS (upregulation of a control region activated by visual scenes)
Number of subjects: 43
Study 26841217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Advice (comprehensive dietary and lifestyle intervention over the course of pregnancy including dietary, exercise and behavioural strategies, delivered by a research dietician and research assistants)
Number of subjects: 970
Study 26841217 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 970
Study 24506318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 60
Study 24506318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60